CO 058: NANOPARTICLES AS DRUG CARRIERS: CHARACTERISTICS AND PERSPECTIVES

Excerpt:


J Pharm Pharmacogn Res 2(Suppl. 1): S35, 2014 Special supplement with the abstract book of LATINFARMA 2013 Oral Communication CO 058: NANOPARTICLES AS DRUG CARRIERS: CHARACTERISTICS AND PERSPECTIVES Oropesa-Nuñez R1, Jáuregui-Haza U2. 1Centro de Estudios Avanzados de Cuba (CEAC). Carretera San Antonio, Km 1 1/2, Valle Grande, La Lisa, La Habana, Cuba 2Instituto Superior de … Continue reading CO 058: NANOPARTICLES AS DRUG CARRIERS: CHARACTERISTICS AND PERSPECTIVES

J Pharm Pharmacogn Res 2(Suppl. 1): S35, 2014

Special supplement with the abstract book of LATINFARMA 2013

Oral Communication

CO 058: NANOPARTICLES AS DRUG CARRIERS: CHARACTERISTICS AND PERSPECTIVES

Oropesa-Nuñez R1, Jáuregui-Haza U2.

1Centro de Estudios Avanzados de Cuba (CEAC). Carretera San Antonio, Km 1 1/2, Valle Grande, La Lisa, La Habana, Cuba
2Instituto Superior de Tecnologías y Ciencias Aplicadas (InSTEC). Ave. Salvador Allende y Luaces, Plaza de la Revolución, La Habana, Cuba. E-mail: ulises.jauregui@infomed.sld.cu
Abstract

Nanoparticles can copy or modify biological processes because they propose solutions to the old problems associated with solubility, bioavailability, immunocompatibility and cytotoxicity of many traditional drugs. Carbon nanotubes are an example of nanoparticles and nanotechnology due to their small diameters. They can be manipulated chemically and physically. Besides, they are mainly used in nanomedicine as carriers and as excipients to obtain different drug delivery systems. In this work, the state of the art of the research on nanoparticles as drug carriers for medical applications, with emphasis on their properties, determination of physico-chemical properties and carbon nanotubes applications is analyzed. It is demonstrated that drug formulation and administration has been changed with the advances of nanotechnology. The application of nanoparticles in medicine includes their use as carriers through the functionalization or drug encapsulation. With the use of nanoformulations, an important amount of pharmaceuticals have improved their therapeutic action. The biomedical applications of carbon nanotubes have open a way to a new field in therapy and medical diagnosis. The main part of these applications might consist on the implant of nanotubes or functionalized nanotubes in patients. However, the use of carbon nanotubes in medicine depends on the evaluation of their toxicity in humans.

Toxicity evaluation of Ruta angustifolia leaves ethanolic extract
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 437-447, May-June 2023. DOI: https://doi.org/10.56499/jppres23.1609_11.3.437 Original Article Acute and repeated dose 28-day oral toxicity of Ruta angustifolia Pers. leaves ethanolic extract in Wistar rats [Toxicidad oral aguda y por dosis repetidas durante 28 días del extracto etanólico de hojas de Ruta angustifolia Pers. en ratas Wistar] Tutik … Continue reading Toxicity evaluation of Ruta angustifolia leaves ethanolic extract
Adolescents in Indonesia and COVID-19 pandemic
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 426-436, May-June 2023. DOI: https://doi.org/10.56499/jppres22.1560_11.3.426 Original Article Perception, mental health, and social media exposure on adolescents in Indonesia during COVID-19 pandemic [Percepción, salud mental y exposición a los medios sociales en adolescentes de Indonesia durante la pandemia de COVID-19] Efa Nugroho1*, Alfiana Ainun Nisa1, Widya Hary Cahyati1, … Continue reading Adolescents in Indonesia and COVID-19 pandemic
Decaffeinated green tea and coffee extracts and metabolic syndrome
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 414-425, May-June 2023. DOI: https://doi.org/10.56499/jppres23.1593_11.3.414 Original Article Decaffeinated green tea and green coffee extracts as metformin’s add-on enhance metabolic syndrome risk factors and improve the cardiac insulin-gene-related pathway [Extractos de té verde y café verde descafeinados como complemento de la metformina mejoran los factores de riesgo del … Continue reading Decaffeinated green tea and coffee extracts and metabolic syndrome

© 2013-2020 by the authors; licensee JPPRes, Antofagasta, Chile. This journal is an open-access journal distributed under the terms and conditions of the Creative Commons Attribution license-Non Commercial 4.0 international. The content on this site is intended for health professionals. If you are not a health professional, please talk to your doctor about any doubts or concerns regarding your health

Made with ♥ by AVAGAX Studio